Shanghai Pharmaceuticals Holding Co., Ltd
601607
株式のランク
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
株価
$2.43
時価総額
$8.09B
変化（1日）
-1.16%
変化（1年）
-5.94%
国
CN
取引 Shanghai Pharmaceuticals Holding Co., Ltd (601607)
カテゴリー
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd（601607）の営業利益率
October 2026 時点の営業利益率 TTM: 2.78%
Shanghai Pharmaceuticals Holding Co., Ltd の最新の財務報告と株価によると、現在の営業利益率（TTM）は 2.78% です。2024 年末時点では 2.96% でした。
Shanghai Pharmaceuticals Holding Co., Ltd の営業利益率の履歴（2001 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 2.78% | -20.80% |
| 2025 | 3.51% | 18.58% |
| 2024 | 2.96% | 0.34% |
| 2023 | 2.95% | -24.16% |
| 2022 | 3.89% | 2.37% |
| 2021 | 3.80% | 1.60% |
| 2020 | 3.74% | 12.31% |
| 2019 | 3.33% | 1.83% |
| 2018 | 3.27% | -18.25% |
| 2017 | 4.00% | 10.19% |
| 2016 | 3.63% | 4.01% |
| 2015 | 3.49% | -1.41% |
| 2014 | 3.54% | -9.00% |
| 2013 | 3.89% | 1.04% |
| 2012 | 3.85% | -26.39% |
| 2011 | 5.23% | -5.77% |
| 2010 | 5.55% | 193.65% |
| 2009 | 1.89% | 90.91% |
| 2008 | 0.99% | 12.50% |
| 2007 | 0.88% | 18.92% |
| 2006 | 0.74% | 29.82% |
| 2005 | 0.57% | -58.99% |
| 2004 | 1.39% | -37.95% |
| 2003 | 2.24% | -15.47% |
| 2002 | 2.65% | -32.23% |
| 2001 | 3.91% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 1.62% | -99.42% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.63% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -96.69% |
AU
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。